Literature DB >> 20222491

An analysis of vulvar necrotizing fasciitis in the unique and ethnically diverse Hawaiian population.

John Nakayama1, Raydeen Busse.   

Abstract

Vulvar necrotizing fasciitis is a surgical emergency with a high rate of morbidity and mortality. Our case series adds seven patients to the literature and presents the first group that is predominantly of Pacific-Islander origin. This study not only confirms traditional risk factors such as diabetes mellitus, obesity and hypertension but investigates ethnicity and socioeconomic status as risk factors. Also presented is a case of recurrent necrotizing fasciitis initially involving the vulva, then the back. In any patient for which there is suspicion of vulvar necrotizing fasciitis, surgical diagnosis remains the gold standard and facilitates rapid debridement of all necrotic tissues. Aggressive surgical debridement with broad spectrum antibiotic coverage is required to minimize mortality.

Entities:  

Mesh:

Year:  2010        PMID: 20222491      PMCID: PMC3104625     

Source DB:  PubMed          Journal:  Hawaii Med J        ISSN: 0017-8594


  16 in total

1.  Recurrent necrotizing fasciitis in complement C4 deficiency.

Authors:  P D Kumar
Journal:  Ann Intern Med       Date:  2001-10-16       Impact factor: 25.391

2.  Necrotizing fasciitis and toxic shock-like syndrome caused by group B streptococcus.

Authors:  B Holmström; E W Grimsley
Journal:  South Med J       Date:  2000-11       Impact factor: 0.954

3.  Necrotizing fasciitis of the vulva.

Authors:  H Stephenson; D J Dotters; V Katz; W Droegemueller
Journal:  Am J Obstet Gynecol       Date:  1992-05       Impact factor: 8.661

4.  Recurrent necrotizing fasciitis caused by methicillin-resistant Staphylococcus aureus.

Authors:  C-H Wong; S-H Tan; A Kurup; A B-H Tan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-11-13       Impact factor: 3.267

5.  Predictors of mortality and limb loss in necrotizing soft tissue infections.

Authors:  Daniel A Anaya; Kerry McMahon; Avery B Nathens; Stephen R Sullivan; Hugh Foy; Eileen Bulger
Journal:  Arch Surg       Date:  2005-02

6.  Differentiation of necrotizing fasciitis and cellulitis using MR imaging.

Authors:  M R Schmid; T Kossmann; S Duewell
Journal:  AJR Am J Roentgenol       Date:  1998-03       Impact factor: 3.959

7.  Cellulitis incidence in a defined population.

Authors:  S M Ellis Simonsen; E R van Orman; B E Hatch; S S Jones; L H Gren; K T Hegmann; J L Lyon
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

8.  Postpartum and vulvar necrotizing fasciitis. Early clinical diagnosis and histopathologic correlation.

Authors:  J O Schorge; S R Granter; L H Lerner; S Feldman
Journal:  J Reprod Med       Date:  1998-07       Impact factor: 0.142

9.  Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality.

Authors:  Chin-Ho Wong; Haw-Chong Chang; Shanker Pasupathy; Lay-Wai Khin; Jee-Lim Tan; Cheng-Ooi Low
Journal:  J Bone Joint Surg Am       Date:  2003-08       Impact factor: 5.284

10.  Necrotizing fasciitis in gynecologic and obstetric patients: a surgical emergency.

Authors:  Donald G Gallup; Murray A Freedman; Ramon V Meguiar; Sandra N Freedman; Thomas E Nolan
Journal:  Am J Obstet Gynecol       Date:  2002-08       Impact factor: 8.661

View more
  3 in total

1.  Necrotizing fasciitis: epidemiology and clinical predictors for amputation.

Authors:  Patcharin Khamnuan; Wilaiwan Chongruksut; Kijja Jearwattanakanok; Jayanton Patumanond; Apichat Tantraworasin
Journal:  Int J Gen Med       Date:  2015-05-14

2.  Necrotizing fasciitis arising from squamous cell carcinoma of the vulva.

Authors:  Dua Cebeci; Şirin Yaşar; Tevfik Eker; Görgün Bayraktaroğlu
Journal:  Dermatol Reports       Date:  2022-03-17

3.  Clinical predictors for severe sepsis in patients with necrotizing fasciitis: an observational cohort study in northern Thailand.

Authors:  Patcharin Khamnuan; Wilaiwan Chongruksut; Kijja Jearwattanakanok; Jayanton Patumanond; Apichat Tantraworasin
Journal:  Infect Drug Resist       Date:  2015-07-16       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.